INDIANAPOLIS–(BUSINESS WIRE)–Aug 29, 2018–Healthx, Inc., the leading healthcare technology engagement platform announces the appointment of healthcare technology industry veteran Gene Cattarina as new CEO and Mark Rapoport as CFO.
Prior to joining Healthx, Cattarina established an impressive track record of success, leading numerous healthcare technology companies through major growth in business sectors including healthcare information systems, software, products, devices, and professional services. Most recently he was CEO of SafeOp Surgical, Inc. (now an Alphatec company) the developer and provider of the EPAD™ System, a unique, simple-to-use, and cost-effective neurological monitoring solution. Previous to SafeOp, he was President and CEO of Capsule Technologies (now a part of Qualcomm Life) the industry leading provider of medical device integration solutions. Gene has also held CEO and President positions at Lynx Medical Systems; Landacorp, Inc.; Medicode; and TDS Healthcare Systems, now part of Allscripts.
Joining Cattarina is Mark Rapoport as Chief Financial Officer. Rapoport also has a rich history of leadership in healthcare technology, holding CFO positions at Visioneering Technologies, Inc. (VTI) and Capsule Technologie SAS, as well as President & CEO of Thomas, Thomas & Walsh, Inc., and COO and CFO of Landacorp, Inc.
About Healthx: At Healthx we empower the healthcare experience, helping people live longer, healthier lives while lowering healthcare costs by keeping health plans, members, and providers connected. Our platform orchestrates the complex healthcare journey by delivering personalized experiences that drive cost savings and improve quality of care. With Healthx, engaged members are healthier members, and healthier members significantly reduce healthcare costs.
Seth T. Godwin, 206-383-5216